Corcept Therapeutics (CORT +19.66%) took its investors for quite a ride on Hump Day. The commercial-stage biotech earned its latest nod from a regulator that afternoon and, not su ...

Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the 12 Best UK Stocks to Buy According to Hedge Funds. On March 19, 2026, ...

According to TipRanks.com, Stranahan is a 4-star analyst with an average return of 5.0% and a 49.9% success rate. Stranahan covers the Healthcare sector, focusing on stocks such as Day One ...

U.S. large-cap healthcare stocks have delivered modest year-to-date gains in 2026, holding steady into March amid its defensive appeal. Below is a list of the top 10 large-cap healthcare stocks with ...

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over ...

BlackRock Health Sciences Trust II trades at a 12.76% discount to NAV, near its deepest 1-year discount, but faces risks.

Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) were both leaders in the coronavirus vaccine market. However, as sales of these products have declined significantly in recent years ...

Generate Biomedicines IPO highlights AI-driven drug discovery, strong backing, promising pipeline, and investor confidence signals.

Moderna CEO Stéphane Bancel’s total compensation remained remarkably stable last year at $19.9 million, even as the vaccines company navigated a “challenging regulatory and business environment.” ...

Is IBRX a good stock to buy now? We came across a bullish thesis on ImmunityBio, Inc. on r/pennystocks by Bailey-96.

Moderna appears to have dodged the worst-case scenario in its legal battle with two biopharmaceutical companies that accused the drugmaker of infringing on their patents.